- Blink Tabs
- Personal Tools
- Business Tools
- Instruction Tools
- Research Tools
Learn about the Institutional Biosafety Committee and see a list of its members.
Institutional Biosafety Committee (IBC) |
|
|---|---|
|
The major responsibilities of this committee include:
Read the complete committee charge. |
|
Ex officio |
Departments |
| Benedict, Steve | Director, Environment, Health & Safety |
| Clark, Mark | SOM - Department Safety Officer |
| Miyanohara, Atsushi | Director of the Vector Lab (Voting) |
| Richter, Phil | Veterinarian Representative (Voting) |
| Sarmiento, Bundy | Chair, Veterans Affairs Biosafety Committee |
| Siddiqui, Aleem (Chair) | Department of Medicine (Voting) |
| Smith, Ken | Research Safety Manager |
| Torriani, Francesca | Medical Director – Infection Prevention/ Clinical Epidemiology Unit (Voting) |
| Wong, Brenda | Biological Safety Officer (Voting) |
Appointed |
Departments |
| Crawford, Nigel | Plant Pathogen Expert |
| Erickson, Kirsten | Staff Representative |
| Fierer, Joshua | School of Medicine/Infectious Agents/ Recombinant DNA |
| Friedmann, Theodore | Human Gene Therapy Clinical Trials Representative |
| Johnson, Randall | General Campus Faculty Representative |
| Letendre, Scott | Recombinant DNA/ Infectious Disease Representative |
| Peter, Christopher | Community Representative |
| Ramras, Donald | Community Representative |
| Schooley, Robert | School of Medicine Faculty Representative |
| Schrenzel, Mark | Community Representative |
| Vacant | Recombinant DNA/ Gene Therapy Representative |
The IBC is advisory to the chancellor through the vice chancellor – External and Business Affairs on all matters relating to the safe use of hazardous biological materials and organisms. It is the committee's responsibility to establish, monitor, and enforce policies and procedures which meet or exceed applicable norms or regulations for biohazardous materials and/or recombinant DNA, including gene transfer clinical trials. Any use of biohazardous materials and/or recombinant DNA must be reviewed and approved by the committee (or the biological safety officer operating within guidelines established by the committee). The committee has the authority to impose disciplinary measures in cases where there is willful or negligent violation of UCSD's established biosafety practices and procedures. The sanctions are subject to review and/or modification by the chancellor. The committee shall maintain diverse membership representing the community and a variety of university interests. Non-committee faculty or staff with a particular expertise will be asked to advise the committee when the need arises.